SlideShare a Scribd company logo
1 of 24
Download to read offline
WHO guidelines on
transfer of
technology
Dr. Kavita Bahmani
Assistant Professor
GJUS&T, Hisar, Haryana, India
Content Layout
1. Introduction
2. Organization and management
3. Production: transfer (processing, packaging and cleaning)
4. Quality control: analytical method transfer
5. Premises and equipment
6. Documentation
7. Qualification and validation
1.
INTRODUCTION
Transfer of processes to an alternative
site occurs at some stage in the
life-cycle of most products, from
development, scale-up, manufacturing,
production and launch, to the post-
approval phase.
Transfer of technology is defined as “a
logical procedure that controls
the transfer of any process together
with its documentation and
professional
expertise between development and
manufacture or between manufacture
sites”.
Transfer of technology requires a
documented, planned approach using
trained and knowledgeable personnel
working within a quality system, with
documentation of data covering all
aspects of development, production
and
quality control.
The project plan should encompass
the quality aspects of the project and
be based upon the principles of quality
risk management;
Technology transfer can be considered
successful if there is documented
evidence that the RU can routinely
reproduce the transferred product,
processor method against a
predefined set of specifications as
agreed with the SU.
2. ORGANIZATION AND
MANAGEMENT
Organization and management
• Transfer comprises an SU and an RU. In some circumstances there may be an additional unit
which will be responsible for directing, managing and approving the transfer.
• There is a formal agreement between the parties, which specifies the responsibilities before,
during and after transfer.
• There should be a project management plan which identifies and controls all the necessary
activities identified at the start of the undertaking.
The transfer protocol
Objective, scope, key personnel
and their responsibilities
a parallel comparison of materials,
methods and equipment, the
transfer stages with documented
evidence that each critical stage
has been satisfactorily
accomplished before the next
commences
identification of critical control
points, experimental design and
acceptance criteria for analytical
methods, information on trial
production batches, qualification
batches and process validation
change control for any process
deviations encountered,
assessment of end-product
arrangements for keeping
retention samples of active
ingredients, intermediates and
finished products, and information
on reference substances where
applicable; and conclusion,
including signed-off approval by
project manager.
IT CONSIST OF FOLLOWINGS
Points to be followed
• The SU should provide the necessary validation documentation for the process
and its support functions
• The SU should provide criteria and information on hazards and critical steps
associated with the product, process or method to be transferred, to serve as a
basis for a quality risk management
• The SU or third party should assess the suitability and degree of preparedness of
the RU before transfer, with regard to premises, equipment and support services
(e.g. purchasing and inventory control mechanisms, quality control (QC)
procedures, documentation, computer validation, site validation, equipment
qualification, water for pharmaceutical production and waste management).
The SU and the RU should jointly verify that the following,
satisfactorily completed, validation protocols are available
or not
The SU and the RU should
jointly implement any training
programmes that may be
required specific to the product,
process or method to be
transferred, e.g. on analytical
methods or equipment usage,
and assess training outcomes.
Any changes and adaptations
made during the course of the
technology transfer should be
fully documented.
The SU and the RU should
jointly document the execution of
the transfer protocol in a transfer
of technology summary in a
report.
3. Production: transfer (processing,
packaging
and cleaning
3. Production: transfer (processing, packaging
and cleaning)
The SU and the RU should jointly develop a protocol for the transfer
of relevant information related to the process under consideration from the
SU to the RU, as well as the development of a comparable process at the RU.
Consideration should be given to the technical expertise, site
technology and site capabilities for the RU. It should be identified upfront
by the SU of any process robustness issues so that plans may be put in place
at the RU
The RU should be able to accommodate the intended production
capacity. If possible, it should be established at the outset whether the
intention is to perform single-batch manufacture, continuous production or
campaigns.
Starting
materials
Active
pharmaceutic
al ingredients
(API)
Excepients
Information on
process and finished
pharmaceutical
products information
Packaging
Cleaning
Implementation of
processing, packaging
and cleaning systems
BASIS OF TECHNOLOGY
TRANSFER IN PRODUCTION
4. QUALITY CONTROL
4. Quality control: analytical method
transfer
Transfer of analytical methods should
accommodate all the analytical
testing required to demonstrate
compliance of the product to be
transferred
with the registered specification
Analytical methods used to test
pharmaceutical products, starting
materials, packaging components
and cleaning (residue) samples, if
applicable, should be implemented at
the testing laboratory before testing
of samples for process validation
studies is performed by the RU.
A protocol defining the steps
should be prepared for
transfer of
analytical methods.
methods. The analytical methods
transfer protocol should include
a description of the objective, scope
and responsibilities of the SU and the
RU
Process validation samples may be
tested at the RU, the SU or a third
laboratory
SU’s responsibilities for the transfer of analytical
methods
Provide method-
specific training for
analysts and other
quality control staff,
if required
Assist in analysis
of QC testing
results
Define all methods
to be transferred
for testing a given
product, starting
material or cleaning
sample
Define experimental
design, sampling
methods and
acceptance criteria
Provide any
validation reports for
methods under
transfer and
demonstrate their
robustness
Provide details of the
equipment used, as necessary
(part of validation report, if
available) and any standard
reference samples
Provide approved
procedures used in
testing
RU’s responsibilities
Review analytical
methods provided by the
SU, and formally agree on
acceptance criteria before
execution of the transfer
protocol
Ensure that the
necessary
equipment for QC is
available and
qualified at the RU
site.
The equipment used by the RU
during the analytical transfer
should meet appropriate
specifications to ensure the
requirements of the method or
specification are met
Ensure that adequately
trained and experienced
personnel are in place for
analytical testing
Perform the
appropriate level of
validation to
support the
implementation of
the methods
Generate and obtain
approval of transfer
reports
Appropriate training
should be provided
and all training
activities and
outcomes should be
documented.
Reference to
compendial
monographs where
available, is
expected.
5. PREMISES &
EQUIPMENT
Premises
• The SU should provide information to the RU on the layout, construction and finish of
buildings and services
• The SU should provide information on relevant health, safety and environmental issues
• Risks of the manufacturing processes
• Health and safety requirements to minimize operator exposure
• Emergency planning considerations
• Identification of waste streams and provisions for re-use, recycling and/or disposal
Equipment
• The SU should provide a list of equipment, makes and models involved in the
manufacture, filling, packing and or control of the product, process or method to
be transferred, together with existing qualification and validation documentation.
• The RU should review the information provided by the SU together with its own
inventory list including the qualification status (IQ, OQ, PQ) of all equipment and
systems, and perform a side-by-side comparison of equipment at the two sites in
terms of their functionality, makes, models and qualification status.
• Any modification of existing equipment that needs to be adapted to become
capable of reproducing the process being transferred should be documented in
the transfer project plan
6. DOCUMENTATION
Examples of documentation for transfer of
technology (TOT)
Project implementation plan TOT protocol
Side-by-side comparison with RU facility and buildings; gap
Analysis Qualification protocol and report
Training protocols, assessment results
Analytical methods transfer protocol and report
Side-by-side comparison with RU equipment (makes, models, qualification status) Gap analysis Qualification and
validation protocol and report
History of process development at RU Product- and site-specific cleaning SOPs at RU Cleaning validation protocol and
report
7. QUALIFICATION &
VALIDATION
The extent of qualification and
or validation to be performed
should be determined on the
basis of risk management
principles
THANK YOU

More Related Content

Similar to pptonwho-200801140321.pdf

Technology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryTechnology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryPranjalWagh1
 
Technology development & transfer by devill
Technology development & transfer by devillTechnology development & transfer by devill
Technology development & transfer by devillSnake EYE
 
TECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptx
TECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptxTECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptx
TECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptxAbhishek Borkar15
 
Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...
Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...
Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...Audumbar Mali
 
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]Flu Plant
 
Phụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩm
Phụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩmPhụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩm
Phụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩmCông ty Cổ phần Tư vấn Thiết kế GMP EU
 
Industrial pharmacy ii
Industrial pharmacy   iiIndustrial pharmacy   ii
Industrial pharmacy iiWashifIslam
 
DOCUMENTATION IN TECHNOLOGY TRANSFER.pptx
DOCUMENTATION IN TECHNOLOGY TRANSFER.pptxDOCUMENTATION IN TECHNOLOGY TRANSFER.pptx
DOCUMENTATION IN TECHNOLOGY TRANSFER.pptxkrutikanagpurkar1
 
TRS 937, 2006 ( validation HVAC).pdf
TRS 937, 2006 ( validation HVAC).pdfTRS 937, 2006 ( validation HVAC).pdf
TRS 937, 2006 ( validation HVAC).pdfleminhle2
 
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATION
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATIONValidation, scope of validation, URS , WHO GUIDELINES FOR VALIDATION
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATIONManikant Prasad Shah
 
Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)RushikeshPalkar1
 
PHARMACEUTICAL VALIDATION
 PHARMACEUTICAL  VALIDATION PHARMACEUTICAL  VALIDATION
PHARMACEUTICAL VALIDATIONSACHIN C P
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validationDhruviParmar
 
Validation of Pharmaceutical Dosage Form
Validation of Pharmaceutical Dosage FormValidation of Pharmaceutical Dosage Form
Validation of Pharmaceutical Dosage FormDiksha Kumari
 
Validation of pharmaceutical dosage form
Validation of pharmaceutical dosage formValidation of pharmaceutical dosage form
Validation of pharmaceutical dosage formanurag chanda
 

Similar to pptonwho-200801140321.pdf (20)

Technology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryTechnology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical Industry
 
Technology development & transfer by devill
Technology development & transfer by devillTechnology development & transfer by devill
Technology development & transfer by devill
 
TECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptx
TECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptxTECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptx
TECHNOLOGY DEVELOPMENT AND TRANSFER PPT..pptx
 
Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...
Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...
Industrial Pharmacy-II (IP-II) Unit 2:- chapter:- 2 Technology Development an...
 
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
Transfer technologypharmaceuticalmanufacturingtrs961annex7[1]
 
Phụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩm
Phụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩmPhụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩm
Phụ lục 7. Hướng dẫn của WHO trong chuyển giao công nghệ sản xuất dược phẩm
 
Industrial pharmacy ii
Industrial pharmacy   iiIndustrial pharmacy   ii
Industrial pharmacy ii
 
DOCUMENTATION IN TECHNOLOGY TRANSFER.pptx
DOCUMENTATION IN TECHNOLOGY TRANSFER.pptxDOCUMENTATION IN TECHNOLOGY TRANSFER.pptx
DOCUMENTATION IN TECHNOLOGY TRANSFER.pptx
 
TRS 937, 2006 ( validation HVAC).pdf
TRS 937, 2006 ( validation HVAC).pdfTRS 937, 2006 ( validation HVAC).pdf
TRS 937, 2006 ( validation HVAC).pdf
 
Process validation
Process validationProcess validation
Process validation
 
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATION
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATIONValidation, scope of validation, URS , WHO GUIDELINES FOR VALIDATION
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATION
 
P rocess validation 1
P rocess validation 1P rocess validation 1
P rocess validation 1
 
Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)Validation ( process validation, TT from R&D to pilot plant)
Validation ( process validation, TT from R&D to pilot plant)
 
Validation.pptx
Validation.pptxValidation.pptx
Validation.pptx
 
PHARMACEUTICAL VALIDATION
 PHARMACEUTICAL  VALIDATION PHARMACEUTICAL  VALIDATION
PHARMACEUTICAL VALIDATION
 
4 validation jntu pharmacy
4 validation jntu pharmacy4 validation jntu pharmacy
4 validation jntu pharmacy
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Validation of Pharmaceutical Dosage Form
Validation of Pharmaceutical Dosage FormValidation of Pharmaceutical Dosage Form
Validation of Pharmaceutical Dosage Form
 
Phụ lục 15 GMP EU. Chuẩn hóa và thẩm định
Phụ lục 15 GMP EU. Chuẩn hóa và thẩm địnhPhụ lục 15 GMP EU. Chuẩn hóa và thẩm định
Phụ lục 15 GMP EU. Chuẩn hóa và thẩm định
 
Validation of pharmaceutical dosage form
Validation of pharmaceutical dosage formValidation of pharmaceutical dosage form
Validation of pharmaceutical dosage form
 

Recently uploaded

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...RKavithamani
 

Recently uploaded (20)

Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
Privatization and Disinvestment - Meaning, Objectives, Advantages and Disadva...
 

pptonwho-200801140321.pdf

  • 1. WHO guidelines on transfer of technology Dr. Kavita Bahmani Assistant Professor GJUS&T, Hisar, Haryana, India
  • 2. Content Layout 1. Introduction 2. Organization and management 3. Production: transfer (processing, packaging and cleaning) 4. Quality control: analytical method transfer 5. Premises and equipment 6. Documentation 7. Qualification and validation
  • 4. Transfer of processes to an alternative site occurs at some stage in the life-cycle of most products, from development, scale-up, manufacturing, production and launch, to the post- approval phase. Transfer of technology is defined as “a logical procedure that controls the transfer of any process together with its documentation and professional expertise between development and manufacture or between manufacture sites”. Transfer of technology requires a documented, planned approach using trained and knowledgeable personnel working within a quality system, with documentation of data covering all aspects of development, production and quality control. The project plan should encompass the quality aspects of the project and be based upon the principles of quality risk management; Technology transfer can be considered successful if there is documented evidence that the RU can routinely reproduce the transferred product, processor method against a predefined set of specifications as agreed with the SU.
  • 6. Organization and management • Transfer comprises an SU and an RU. In some circumstances there may be an additional unit which will be responsible for directing, managing and approving the transfer. • There is a formal agreement between the parties, which specifies the responsibilities before, during and after transfer. • There should be a project management plan which identifies and controls all the necessary activities identified at the start of the undertaking.
  • 7. The transfer protocol Objective, scope, key personnel and their responsibilities a parallel comparison of materials, methods and equipment, the transfer stages with documented evidence that each critical stage has been satisfactorily accomplished before the next commences identification of critical control points, experimental design and acceptance criteria for analytical methods, information on trial production batches, qualification batches and process validation change control for any process deviations encountered, assessment of end-product arrangements for keeping retention samples of active ingredients, intermediates and finished products, and information on reference substances where applicable; and conclusion, including signed-off approval by project manager. IT CONSIST OF FOLLOWINGS
  • 8. Points to be followed • The SU should provide the necessary validation documentation for the process and its support functions • The SU should provide criteria and information on hazards and critical steps associated with the product, process or method to be transferred, to serve as a basis for a quality risk management • The SU or third party should assess the suitability and degree of preparedness of the RU before transfer, with regard to premises, equipment and support services (e.g. purchasing and inventory control mechanisms, quality control (QC) procedures, documentation, computer validation, site validation, equipment qualification, water for pharmaceutical production and waste management).
  • 9. The SU and the RU should jointly verify that the following, satisfactorily completed, validation protocols are available or not The SU and the RU should jointly implement any training programmes that may be required specific to the product, process or method to be transferred, e.g. on analytical methods or equipment usage, and assess training outcomes. Any changes and adaptations made during the course of the technology transfer should be fully documented. The SU and the RU should jointly document the execution of the transfer protocol in a transfer of technology summary in a report.
  • 10. 3. Production: transfer (processing, packaging and cleaning
  • 11. 3. Production: transfer (processing, packaging and cleaning) The SU and the RU should jointly develop a protocol for the transfer of relevant information related to the process under consideration from the SU to the RU, as well as the development of a comparable process at the RU. Consideration should be given to the technical expertise, site technology and site capabilities for the RU. It should be identified upfront by the SU of any process robustness issues so that plans may be put in place at the RU The RU should be able to accommodate the intended production capacity. If possible, it should be established at the outset whether the intention is to perform single-batch manufacture, continuous production or campaigns.
  • 12. Starting materials Active pharmaceutic al ingredients (API) Excepients Information on process and finished pharmaceutical products information Packaging Cleaning Implementation of processing, packaging and cleaning systems BASIS OF TECHNOLOGY TRANSFER IN PRODUCTION
  • 14. 4. Quality control: analytical method transfer Transfer of analytical methods should accommodate all the analytical testing required to demonstrate compliance of the product to be transferred with the registered specification Analytical methods used to test pharmaceutical products, starting materials, packaging components and cleaning (residue) samples, if applicable, should be implemented at the testing laboratory before testing of samples for process validation studies is performed by the RU. A protocol defining the steps should be prepared for transfer of analytical methods. methods. The analytical methods transfer protocol should include a description of the objective, scope and responsibilities of the SU and the RU Process validation samples may be tested at the RU, the SU or a third laboratory
  • 15. SU’s responsibilities for the transfer of analytical methods Provide method- specific training for analysts and other quality control staff, if required Assist in analysis of QC testing results Define all methods to be transferred for testing a given product, starting material or cleaning sample Define experimental design, sampling methods and acceptance criteria Provide any validation reports for methods under transfer and demonstrate their robustness Provide details of the equipment used, as necessary (part of validation report, if available) and any standard reference samples Provide approved procedures used in testing
  • 16. RU’s responsibilities Review analytical methods provided by the SU, and formally agree on acceptance criteria before execution of the transfer protocol Ensure that the necessary equipment for QC is available and qualified at the RU site. The equipment used by the RU during the analytical transfer should meet appropriate specifications to ensure the requirements of the method or specification are met Ensure that adequately trained and experienced personnel are in place for analytical testing Perform the appropriate level of validation to support the implementation of the methods Generate and obtain approval of transfer reports Appropriate training should be provided and all training activities and outcomes should be documented. Reference to compendial monographs where available, is expected.
  • 18. Premises • The SU should provide information to the RU on the layout, construction and finish of buildings and services • The SU should provide information on relevant health, safety and environmental issues • Risks of the manufacturing processes • Health and safety requirements to minimize operator exposure • Emergency planning considerations • Identification of waste streams and provisions for re-use, recycling and/or disposal
  • 19. Equipment • The SU should provide a list of equipment, makes and models involved in the manufacture, filling, packing and or control of the product, process or method to be transferred, together with existing qualification and validation documentation. • The RU should review the information provided by the SU together with its own inventory list including the qualification status (IQ, OQ, PQ) of all equipment and systems, and perform a side-by-side comparison of equipment at the two sites in terms of their functionality, makes, models and qualification status. • Any modification of existing equipment that needs to be adapted to become capable of reproducing the process being transferred should be documented in the transfer project plan
  • 21. Examples of documentation for transfer of technology (TOT) Project implementation plan TOT protocol Side-by-side comparison with RU facility and buildings; gap Analysis Qualification protocol and report Training protocols, assessment results Analytical methods transfer protocol and report Side-by-side comparison with RU equipment (makes, models, qualification status) Gap analysis Qualification and validation protocol and report History of process development at RU Product- and site-specific cleaning SOPs at RU Cleaning validation protocol and report
  • 23. The extent of qualification and or validation to be performed should be determined on the basis of risk management principles